Offer - Urjas Oil for just ₹ 1 X
Grasipar is a prescription drug, available for use as Injection. It is typically used for the treatment of Neutropenia.
The optimal dosage of Grasipar is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Grasipar as well, which are listed below. Such side effects of Grasipar normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Grasipar is Moderate for pregnant women and Moderate for women who are breastfeeding. In addition, Grasipar's effects on the liver, heart and kidney are discussed below in the Grasipar related warnings section.
Grasipar is not recommended if you suffer from certain medical conditions as it can have adverse effects. Blood Cancer are examples of such conditions. Some other conditions that can be affected by Grasipar are listed in the contraindications section below.
Drug reaction of Grasipar with other medicines has been reported. Refer to the list below for further details.
In addition to the above precautions for Grasipar, it is important to know that it is safe while driving, and is habit-forming.
Grasipar is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Is the use of Grasipar safe for pregnant women?
Grasipar can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Grasipar right away. Take your doctor's advice before taking it again.
Is the use of Grasipar safe during breastfeeding?
Breastfeeding women may feel side effects of Grasipar. If you see any side effects, stop taking Grasipar immediately and talk to your doctor. Take Grasipar again, only after your doctor's advice.
What is the effect of Grasipar on the Kidneys?
Grasipar has very mild side effects on the kidneys.
What is the effect of Grasipar on the Liver?
Grasipar has very mild side effects on the liver.
What is the effect of Grasipar on the Heart?
You may experience side effects on your heart after taking Grasipar. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Grasipar should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Grasipar unless your doctor advises you to do so -
Is this Grasipar habit forming or addictive?
No, there is no any evidence that Grasipar is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Grasipar does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, Grasipar is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Grasipar for mental disorders.
Interaction between Food and Grasipar
Due to a lack of research, nothing can be said about the consequences of taking Grasipar together with food.
Interaction between Alcohol and Grasipar
Due to lack of research, there is no information about the side effects of taking Grasipar with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neupogen® (Filgrastim)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 876
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 567-560